Future Market Insights5d
Coronary Stents Market Is Anticipated to Reach USD 51.2 Billion by 2032, Growing at a 5.1% CAGR
Abbott, Medtronic, Boston Scientific Corporation ... the market is segmented based on product type (drug-eluting stent (DES), ...
Future Market Insights6d
Industrial Analysis of Coronary Stent in India stands at a valuation USD 1,213.5 Million with a 3.7% CAGR
To improve the management of coronary artery disease and lay the groundwork for future advancements in stent technology, ...
PharmiWeb8d
Global Coronary Artery Bypass Graft Market Set for Resurgence, Projected to Reach USD 22,765.9 Million by 2033
The global coronary artery bypass graft market, valued at USD 17,612.1 million in 2023, is forecast to experience significant growth, reaching an estimated USD 22,765.9 million by 2033. While the ...
Le Lézard8d
Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...
MassDevice12d
The biggest cardiovascular tech stories from TCT 2024
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
Business Wire13d
Drug Device Combination Products Strategic Market Research 2024-2030: Increasing Collaborations Between Pharmaceutical and Medical Device Companies, and Growing Investments in ...
The global market for Drug Device Combination Products was estimated at US$114.8 Billion in 2023 and is projected to reach US$158.7 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This ...
Health Rounds: Adaptable implant may be improvement over heart stents
Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...
TCTMD15d
Lesion-Specific Drug Eluting Stents: Are They Still Needed?
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
EurekAlert!16d
Orbital atherectomy prior to coronary stent implantation does not lead to better outcomes compared to conventional balloon angioplasty
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...
MassDevice16d
Elixir Medical has positive data for drug-eluting bioadaptive implant
Data highlighted the success of DynamX compared to Medtronic’s Resolute Onyx zotarolimus drug-eluting stent (DES). The study ...
TCTMD17d
TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
The Lancet17d
Coronary stenting with bioadaptors
After years of iterative refinements, drug-eluting stents (DES) have become the standard for percutaneous coronary intervention (PCI). 1-year rates of revascularisation and thrombosis with ...